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Abstract The Escherichia coli pdxC(serC) gene codes for a 
transaminase (EC 2.6.1.52). The gene is involved in both 
pyridoxine (vitamin B6) and serine biosynthesis and was over- 
expressed as a MalEIPdxC(SerC) fusion protein. The fusion 
protein was purified by aff'mity chromatography on an amylose 
resin and hydrolyzed in the presence of protease factor Xa. Both 
the fusion protein and the PdxC(SerC) protein were character- 
i~ed (KM value, turnover number, optimum pH). Both enzymes 
used 4-O-phosphoryl-L-threonine rather than 4-hydroxy-L-threo- 
nine as a substrate indicating that the phosphorylated rather than 
the non-phosphorylated amino acid is involved in pyridoxine 
biosynthesis. Pyridoxal phosphate was shown to be the cofactor 
for both enzymes and therefore seems to be involved in its own 
biosynthesis. 
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1 Introduction 
4-Hydroxy-e-threonine is a biosynthetic precursor of vita- 
e fin B6. The amino acid supports growth of E. eoli mutant 
s rains with impaired vitamin B6 biosynthesis [1]. 13C-Labelled 
lcrecursor amino acid is incorporated into carbons 5', 5 and 6 
( f  pyridoxine [1,2], a B6 vitamin. A possible role in vitamin B6 
I~iosynthesis has also been attributed to 4-O-phosphoryl-e- 
t lreonine (Fig. 1, [3]). This compound is thought to be de- 
r ved from 3-hydroxy-4-O-phosphoryl-2-oxobutyrate by trans- 
amination. The transaminase is encoded by pdxC(serC), a 
~ene believed to be involved in both serine and 4-hydroxy-L- 
t lreonine biosynthesis, or its phosphorylated erivatives [3]. 
l~,lutants lacking a functional allele of the gene fail to synthe- 
s ze both serine and vitamin B6 [4~6]. Whereas Dempsey and 
c ~workers have detected phosphoserine aminotransferase ac- 
! vity with 3-O-phospho-e-serine as the substrate [5], evidence 
t)r  3-hydroxy-4-O-phosphoryl-2-oxobutyrate and 4-O-phos- 
1 horyl-e-threonine as intermediates in vitamin B6 formation 
i circumstantial [3,7]. In both transamination reactions, the 
~ mino group of glutamic acid is transferred to the acceptor c~- 
xoacids, yielding the corresponding amino acids and a-oxo- 
lutarate (Fig. 1). If the aminotransferase is a pyridoxal phos- 
t hate (PLP) dependent enzyme, it would mean that pyridoxal 
! hosphate is involved in its own biosynthesis. This in turn 
ould suggest hat pyridoxal phosphate could act in an auto- 
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catalytic fashion, depending on the enzyme kinetics, able to 
stimulate its own production. 
In this paper we describe experiments on the characteriza- 
tion of the pdxC(serC) gene product and the role of 4-0- 
phosphoryl-L-threonine i  vitamin B6 biosynthesis. 
2. Materials and methods 
2.1. Materials" 
E. coli WG 25 [8] and E. coli WG 1145 [9] were obtained from Dr. 
I.D. Spenser, Hamilton, Ont., Canada. E. coli XL 1 blue (fecAl 
endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' proAB lacIqZDM15 
Tnl0 (Tetr)] was from Stratagene, Heidelberg, Germany. E. eoli Tir8 
[10] was obtained from Dr. I. Saint-Girons (Pasteur Institut, Paris, 
France). 
pMAL-c2 (Ap r, lael q, pt~lmalE-lacPOZ') was from NEB, Schwal- 
bach, Germany. pBluescript (KS-) was from Stratagene, Heidelberg, 
Germany. 
Taq polymerase was obtained from Stratagene, Heidelberg, Ger- 
many. 4-Hydroxy-L-threonine was a gift from Dr. H.G. Floss, Seattle, 
WA, USA. Hydroxypyruvate-dimethylketal, hydrolyzed according to 
the supplier's recommendation, and 3-O-phospho-L-serine were ob- 
tained from Sigma, Munich, Germany. 
2.2. Methods" 
2.2.1. Growth of strains. For over-expression f malEIpdxC(serC) 
one liter of rich medium (10 g bacto-tryptone, 5 g yeast extract, 5 g 
NaC1, 2 g glucose, 100 lag/ml ampicillin) was inoculated with a sta- 
tionary preculture (l% inoculum) of E. coli XL 1 blue containing the 
recombinant plasmid (pCD10). Incubation was carried out at 37°C in 
an Infors shaker (180 rpm) until the OD600 reached a value of 0.5. 
IPTG (final concentration 0.3 mM) was added 3 h before harvest o 
induce the expression of malElpdxC(serC). Cells were collected by 
centrifugation. 
For growth of E. eoli Tit8, 13 liters M9 medium (6.8 g Na2HPO4, 
3.0 g KH2PO4, 0.5 g NaC1, 1.0 g NH4C1, 20 ml 20% glucose, 1 ml 
MgSO4 (1 M), 1 ml CaC12 (0.1 M) in 1 1 H20 (pH 7.0)) containing 1
mg/ml thiamine-hydrochloride, w re inoculated with a stationary pre- 
culture (1% inoculum). The cells were grown to the stationary phase 
and collected by centrifugation. 
Growth of E. coli mutant WG 25 (pdxA-) was performed as de- 
scribed in the presence of pyridoxal phosphate [1]. 
2.2.2. Construction of a maIElpdxC(serC) filsion gene 
(pCDIO). The pdxC(serC) gene was generated by PCR using pri- 
mers pdxfo ...... t (5' GAGGGGAATTCGCTCAAATCTTCA 3') and 
pdx ......... (5' CACGGTTAATGTCGACATTTTGG 3') deduced from 
the nucleotide sequence [11] and the genomic DNA of E. coli K 12 to 
prime an amplification product harboring the whole pdxC(serC) cod- 
ing region. The primers were constructed to yield a PCR product 
containing an EeoRI restriction site at the 5' and a SalI site at the 
3' non-coding region. Amplification was carried out in a Trio-Ther- 
moblock (Biometra, G6ttingen, Germany) using Taq polymerase ac- 
cording to the supplier's recommendation. Thirty cycles were carried 
out, each cycle consisting of denaturing at 95°C (30 s), annealing at 
56°C (30 s) and extension at 72°C (65 s). Recombinant plasmids were 
constructed by standard techniques [12] using the vector's EcoRl and 
Sall sites for cloning. For sequencing the cloned PCR product was 
subcloned into pBluescript (KS-) using the gene's flanking EeoRI 
and SalI sites as well as the internal Clal site. Sequencing was per- 
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formed using the standard pBluescript forward and reverse primers. 
In position 292 arginine [11] was found to be replaced by alanine as is 
the case with Yersinia enterocolitica [13] and Salmonella gallinarium 
[14]. We suspect hat the sequence of Duncan and Coggins [11] con- 
tains a reading error, for none of the published PdxC sequences [13- 
16] except hat of Duncan and Coggins [11] was found to have an 
arginine in position 292. 
2.2.3. Purification of MalE/PdxC(SerC). Bacterial cells (5 g wet 
weight) harboring MalE/PdxC(SerC) were suspended in column buf- 
fer (5 ml, 20 mM Tris-HCl, 200 mM NaC1, 1 mM EDTA, pH 7.4) 
and frozen overnight at -20°C. Before ultrasonic treatment (Branson 
sonifier, Danbury, USA, 10 times, 20 s, 50% output at stage 5) cells 
were thawed in a cold water bath. After sedimentation of the cell 
debris (30 min, 10000 xg, 4°C) the supernatant was diluted to about 
2.5 mg protein/ml and passed over a column (2.5x 10 cm, 1 ml/min) 
packed with 15 ml amylose resin (NEB, Schwalbach, Germany, #800- 
21 s) equilibrated with 5 column volumes of Tris-HC1 buffer (specified 
above). The column was washed with 8 volumes of Tris-HC1 buffer, 
and the fusion protein eluted with the same buffer containing 10 mM 
maltose. The yellow-colored fractions containing Mall/PdxC(SerC) 
were combined and concentrated by ultrafiltration ('8050' cell, Ami- 
con, Witten, Germany, using an 'Omega Filter 5K' filter, Filtron). 
2.2.4. Cleavage of the MalE/PdxC(SerC) fusion protein. The 
MalE/PdxC(SerC) fusion protein was cleaved using protease factor 
Xa (NEB) (10 I.tg/mg protein) for 24 h at 4°C. The solution containing 
the PdxC(SerC) enzyme was passed over the amylose column (see 
above) in order to remove the Mall domain. 
2.2.5. Preparation of MalEIPdxB and PdxB. The MalE/PdxB and 
PdxB proteins were prepared as described for the MalEIPdxC(SerC) 
and PdxC(SerC) proteins except hat primers pdxfo~ward (5' CGTG- 
GAATTCCTTGTTGATGAAA 3') and pdx ..... se (5' GGCACGT- 
TAATCTCTTCTAGATGC 3') were employed. 
2.2.6. Enrichment ofhomo-serine kinase. After harvest he cell se- 
diment (43.5 g fresh weight) was resuspended in 43.5 ml buffer A (50 
mM HEPES, pH 7.5, 0.1 M KCI, 1 mM L-threonine, 1 mM L-lysine, 
0.1 mM pyridoxal phosphate, 2 mM EDTA, 5 mM MgC12, 1 mM 
dithioerythritol) and frozen at -20°C. Before ultrasonic treatment 
(Branson sonifier, Danbury, USA, 10 times, 20 s, 50% output at stage 
5) the cell suspension was thawed in a cold water bath. Enrichment of 
the enzyme was modified as described by Shames et al. [17]. This 
involved (NH4)2SO4 precipitation (40% saturation), gel filtration on 
Sephadex G-25, heat treatment at 57°C and dye ligand chromatogra- 
phy on Affi gel blue (Serva, Heidelberg, Germany). The homo-serine 
kinase containing fractions were pooled and concentrated by ultrafil- 
tration (specified above). Determination of homo-serine kinase activ- 
ity was performed according to [10]. 
2.2.Z Enzyme assays. Transamination of 3-O-phosphoryl-pyru- 
vate by MalE/PdxC(SerC) and PdxC(SerC) was observed in a 
coupled assay using the glutamate dehydrogenase-catalyzed conver- 
sion of ct-oxoglutarate o glutamate in the presence of ammonium 
ions as the indicator eaction. The oxidation of NADH was moni- 
tored in a spectrophotometer at 340 nm. The reaction was carried out 
in 0.1 M potassium phosphate buffer, pH 8.2, containing 4 ~tmol/ml 
KF, 0.25 ~tmol/ml ammonium acetate, 0.125 ~tmol/ml glutamic acid, 
25 nmol/ml NADH, 250 pg/ml glutamate dehydrogenase (11 U), 3-0- 
phosphoryl-pyruvate and MalllPdxC(SerC) fusion protein or 
PdxC(SerC) protein, respectively. 
The reverse reaction (4-O-phosphoryl-L-threonine or 3-O-phospho- 
L-serine to its respective 2-oxo acid) was carried out in 0.1 M potas- 
sium phosphate buffer, pH 8.2, 0.125 ~tmol/ml ct-oxoglutarate, 4 
ktmol/ml KF, 250 ~tg/ml glutamate dehydrogenase, MalE/PdxC(SerC) 
or PdxC(SerC) proteins, and 3-O-phospho-L-serine or 4-O-phosphor- 
yl-L-threonine, together with 0.6 ktmol/ml 3-acetylpyridine adenosine 
dinucleotide (APAD) [18]. The reduction of APAD was monitored at 
365 nm. 
Phosphorylation of 4-hydroxy-L-threonine was achieved with en- 
riched homo-serine kinase fractions (see above) in the presence of 4- 
hydroxy-L-threonine and 6.1 mg/ml ATP, incubated for 30 min at 
37°C. Phosphorylation was stopped by heating for l0 rain at 100°C. 
2.2.8. HPLC assays. B6 vitamins were analyzed using a Merck- 
Hitachi L-6200A HPLC apparatus (Darmstadt, Germany), connected 
to a fluorescence detector (Shimadzu RF551 set to 330 nm (excitation) 
and 400 nm (emission)). The samples were separated on a Nucleosil 
100 5SA column (250x4 mm ID) coupled to a Nucleosil 100 5SA 
guard column (30 x4 mm ID) (Macherey-Nagel, DOren, Germany) 
with a flow rate of 1 ml/min. As eluants 0.01 M HC1 (solvent A) 
and potassium phosphate buffer, 0.5 M pH 5 (solvent B) were used. 
Elution was started with solvent A (100%) decreasing to 90% A as 
component B increased from 0 to 10% over the first 6 min, followed 
by an increase to 20% B over the next 2 min. Subsequently B was 
increased to 100% over 7 min. After a plateau (100% B) for 13 min the 
column was reconditioned with 100% A for 15 min. 
3. Results and discussion 
3-O-phospho-L-serine :2-oxoglutarate aminotransferase 
(PdxC(SerC)), an enzyme involved in serine biosynthesis, is 
most likely also involved in the biosynthesis of 4-hydroxy-L- 
threonine, a precursor of the vitamin B6 pyridine ring (Fig. 1). 
pdxC(serC) mutants fail to synthesize both serine and pyri- 
doxine. In order to examine the dual function of the enzyme, 
the corresponding ene, pdxC(serC), was amplified by PCR 
and over-expressed as a MalE/PdxC(SerC) fusion protein (see 
above). The recombinant plasmid encoding the malE~ 
pdxC(serC) sequence complemented the pdxC(serC) deficient 
E. coli mutant WG 1145, indicating that the fusion protein is 
active in vivo. The fusion protein was enriched on an amylose 
column as described above resulting in a single band at 79 
kDa on a Coomassie blue stained SDS polyacrylamide gel. 
The MalEIPdxC(SerC) fusion protein was cleaved by protease 
factor Xa yielding two bands on SDS PAGE;  one of 43 kDa 
represented the MalE domain and the other at 36 kDa had 
the predicted molecular weight for the PdxC(SerC) protein. 
Whereas the fusion protein was stable over several weeks, the 
cleaved protein showed a clear loss of activity within 2 weeks 
at 4°C. 
Both proteins were examined for their PLP content. The 
UV spectrum of the intensely ellow fusion protein was super- 
imposable on that of PdxC(SerC) alone. The shift of the 
maximum from 405 nm to 330 nm during treatment with 
NaBH4 had also been observed for the corresponding transa- 
minase from sheep brain [19]. Reduction with NaBH4 coin- 
cided with loss of 3-O-phospho-c-serine transaminase activity. 
A control spectrum of PdxB (4-O-phosphoerythronate dehy- 
Table 1 
Properties of MalEIPdxC(SerC) and PdxC(SerC) 
KM [~tM] Vma~ ~mol/s/mg] Turnover number [s -1] Optimum pH 








10 1.6x 10 -2 1.33 7.8 
37 7.6 x 10 -3 0.63 8.7 
110 1.0x 10 -3 0.08 8.7 
15 4.5x 10 -2 1.75 8.0 
17 9.9x 10 3 0.39 8.8 
110 3.8x 10 3 0.15 8.3 
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F~g. 1. Hypothetical scheme of pyridoxal phosphate biosynthesis 
st,owing the probable origin of atoms C-5, -5', -6 and N-1. 
P txB -- 4-O-phosphoerythronate dehydrogenase; PdxC(SerC) =3-0- 
pi~ospho-L-serine:2-oxoglutarate minotransferase; PdxH=pyridox- 
ii e-5'-phosphate oxidase. PdxA and PdxJ are of unknown function. 
d:ogenase), another enzyme of the vitamin B6 pathway ([20], 
1 zig. 1), was as expected evoid of maxima at 330 and 405 nm. 
In another experiment the cofactor of PdxC(SerC) was in- 
wstigated after treatment of the enzyme (8 mg) with TCA 
0~nal concentration 4.5%). After neutralization the superna- 
t:,.nt was placed in wells of agar plates containing a suspension 
of the pyridoxine auxotrophic E. coli mutant WG 25 (see [1]). 
Whereas no growth zones were detected in controls with NaC1 
o~" supernatant from TCA precipitated MalElPdxB fusion 
pJ'otein, a clear growth zone was present around the well 
cmtaining the MalElPdxC(SerC) sample. The diameter of 
tile growth zone compared favorably to an equimolar solution 
e I" pyridoxal phosphate. A third approach used to identify the 
c,)factor requirements of the PdxC(SerC) transaminase was 
c trried out by HPLC. After treatment of the TCA superna- 
t:tnt with phosphatase [21] peaks with retention times corre- 
sr}onding to those of authentic samples of pyridoxal (RT 20.6 
nfin) and pyridoxamine (RT 25.9 min) appeared. In a control 
e~periment again using the MalE/PdxB protein no vitamins 
c}uld be detected. Thus, in agreement with former results [6], 
phosphoserine transaminase is a pyridoxal phosphate contain- 
i~'~g enzyme. It is striking that PLP appears to be involved in 
i s own biosynthesis. 
Both the properties of the fusion protein and the authentic 
l'dxC(SerC) enzyme were characterized using multiply 
c)upled assays. Since the substrate for 4-O-phosphoryl-e- 
tlreonine formation, 3-hydroxy-4-O-phosphoryl-2-oxobuty- 
rtte, is not yet available, the forward reaction could only be 
e~amined with the serine pathway-specific substrate 3-0- 
F hosphoryl-pyruvate. Activity of PdxC(SerC) or MalE/ 
l'dxC(SerC), respectively, was determined using glutamate de- 
1"~ ydrogenase reduction of ~x-oxoglutarate to glutamate in the 
r resence of ammonia with concomitant oxidation of NADH. 
"3 he enzymatic properties of the proteins were also determined 
f ~r the reverse reaction with either 3-O-phospho-L-serine or 4- 
~-phosphoryl-L-threonine as substrates and c~-oxoglutarate as 
t ~e amino group acceptor. The glutamate formed was deter- 
runed quantitatively with glutamate dehydrogenase. The in- 
(iicator reaction was monitored by reduction of APAD as 
c ofactor which shifts the equilibrium of the indicator eaction 
i~ the direction of (x-oxoglutarate [18]. Transamination de- 
pended on the presence of enzyme, substrate, cofactor, gluta- 
mate dehydrogenase and ct-oxoglutarate or glutamate. Phos- 
phorylation of 4-hydroxy-L-threonine (see above) was 
performed enzymatically with homo-serine kinase, an enzyme 
of the bacterial threonine pathway. The enzyme was enriched 
from E. coli Tir 8, a strain de-repressed for the enzymes of the 
threonine operon [10,17,22,23]. The amount of 4-O-phosphor- 
yl-L-threonine in each assay was determined as described [10]. 
No activity of PdxC(SerC) or MalE/PdxC(SerC) could be 
detected in controls with denatured homo-serine kinase or in 
the absence of either 4-hydroxy-L-threonine or ATP. 
The properties of both MalE/PdxC(SerC) and PdxC(SerC) 
determined with different substrates are listed in Table 1. The 
data for KM, Vm~x and turnover number are in the same range 
for both the fusion protein and the authentic PdxC(SerC) 
enzyme. Comparison of the data for 3-O-phosphoryl-pyruvate 
with those for 3-O-phospho-L-serine and 4-O-phosphoryl-L- 
threonine shows that 3-O-phosphoryl-pyruvate is a better sub- 
strate for both enzymes. The turnover number for 4-O-phos- 
phoryl-L-threonine is particularly low compared to those for 
3-O-phosphoryl-pyruvate and 3-O-phospho-L-serine. This 
agrees with the KM value for 4-O-phosphoryl-L-threonine, 
which is significantly higher than the data for the other sub- 
strates. In agreement with observations for pyridoxine-5'- 
phosphate oxidase, another enzyme of the PLP pathway 
(compare Fig. 1) [24], these findings again confirm the as- 
sumption of Dempsey [25] that the biosynthesis of B6 vitamins 
in E. coli is catalyzed by a series of 'sluggish enzymes' with 
rather low turnover numbers and consequently rather high 
K~.~ values (because only small amounts of B6 vitamin are 
required). 
Interestingly, no activity of either enzyme could be observed 
with non-phosphorylated substrates, indicating that the phos- 
phorylated rather than the non-phosphorylated form is a pre- 
cursor of the vitamin B 6 pyridine ring. This agrees with recent 
mutant studies [7] and the assumption that phosphorylation 
occurs at an early step during biosynthesis of PLP (compare 
[26]) and with previous results, which show that non-phos- 
phorylated B 6 vitamins (pyridoxine, pyridoxamine) are not 
oxidized by the pdxH gene product ([24]; compare Fig. 1) 
to form the final cofactor PLP. 
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